Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients-Reference-Cited by-同舟云学术

Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients

Published:2015-03-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Saturnino Luciana TM¹,Ceccato Maria GB¹,Cherchiglia Mariangela L²,Andrade Eli lola G²,Giordano Luiz Flavio C³,Acurcio Francisco A¹

Affiliation:

1. Federal University of Minas Gerais; Social Pharmacy; Presidente Antonio Carlos Avenue, 6627 Campus Pampulha Belo Horizonte Minas Gerais Brazil 31270-901

2. Federal University of Minas Gerais; Department of Social and Preventive Medicine; Alfredo Balena Avenue, 190 - Santa Efigenia Belo Horizonte Minas Gerais Brazil 30130-100

3. Hospital Universitário São José; Renal Transplant Department; Rua Aimorés 2896 Belo Horizonte Minas Gerais Brazil 30140073

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009637.pub2/fullpdf

Reference21 articles.

1. Use of sirolimus in solid organ transplantation;Augustine;Drugs,2007

2. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of a de-novo kidney recipients: an open-label, randomised, controlled trial;Budde;Lancet,2011

3. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials;Schulz;BMC Medicine,2010

4. Maintenance Immunosuppression in the renal transplant recipient: an overview;Gaston;American Journal of Kidney Diseases,2001

5. Impact of the new drugs in the cost of maintenance immunosuppression of renal transplantation. Is it justified?;Gentil;Nephrology Dialysis Transplantation,2004